Adenomyosis in Pregnancy—Should It Be Managed in High-Risk Obstetric Units?
Diagnostics · 20.03.2023 · 13 (6) · 1184
DOI: 10.3390/diagnostics13061184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 20.03.2023. Verfasst von Rodrigo Orozco und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Hospital QuirónSalud, 29004 Malaga, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Uterine adenomyosis is an increasingly frequent disorder. Our study aimed to demonstrate the presence of obstetric complications in the population affected by this condition to demonstrate the need for follow-up in high-risk obstetric units. Material and Methods: The data for the study were obtained from TriNetX, LLC, between 2010 and 2020. The outcomes analyzed were intrauterine growth restriction (IUGR), preterm delivery, cesarean delivery, hypertension, abruption placentae, and spontaneous abortion. Seven thousand six hundred and eight patients were included in the cohort of pregnant patients with adenomyosis, and 566,153 women in the cohort of pregnant patients without any history of endometriosis.
Results
Upon calculating the total risk of presenting any of these problems during pregnancy, we obtained an OR = 1.521, implying that a pregnancy with adenomyosis was 52.1% more likely to present some complication. We found: IUGR OR = 1.257 (95% CI: 1.064–1.485) (p = 0.007); preterm delivery OR = 1.422 (95% CI: 1.264–1.600) (p = 0.0001); cesarean delivery OR = 1.099 (95% CI: 1.002–1.205) (p = 0.046); hypertensive disorders OR = 1.177 (95% CI: 1.076–1.288) (p = 0.0001); abruption placentae OR = 1.197 (95% CI: 1.008–1.422) (p = 0.040), and spontaneous abortion OR = 1.529 (95% CI: 1.360–1.718) (p = 0.0001).
Conclusion
We conclude that the review carried out and the data we obtained on increased risk provide sufficient evidence to recommend that patients with adenomyosis should be managed in obstetric high-risk units.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Hospital QuirónSalud, 29004 Malaga, Spain.
- Department of Computer Engineering, Universidad Politécnica, 28040 Madrid, Spain.
- Biomedical Informatics Group, Department of Artificial Intelligence, Computer Engineering, Universidad Politécnica, 28040 Madrid, Spain.
- TriNetX LLC, Cambridge, MA 02140, USA.
- Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
ORCID-Profile: Rodrigo Orozco, José Carlos Vilches, Gema Hernández, Juan Luis Alcázar
Zitieren
APA
Orozco, R., Vilches, J. C., Brunel, I., Lozano, M., Hernández, G., Pérez-Del Rey, D., Meloni, L., & Alcázar, J. L. (2023). Adenomyosis in Pregnancy—Should It Be Managed in High-Risk Obstetric Units?. Diagnostics, 13(6), 1184. https://doi.org/10.3390/diagnostics13061184
Vancouver
Orozco R, Vilches JC, Brunel I, Lozano M, Hernández G, Pérez-Del Rey D, et al. Adenomyosis in Pregnancy—Should It Be Managed in High-Risk Obstetric Units?. Diagnostics. 2023;13(6):1184. doi:10.3390/diagnostics13061184
BibTeX
@article{Orozco2023,
author = {Orozco, Rodrigo and Vilches, José Carlos and Brunel, Ignacio and Lozano, Manuel and Hernández, Gema and Pérez-Del Rey, David and Meloni, Laura and Alcázar, Juan Luis},
title = {Adenomyosis in Pregnancy—Should It Be Managed in High-Risk Obstetric Units?},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {6},
pages = {1184},
doi = {10.3390/diagnostics13061184}
}
EUVIMED